Since it came onto the market in 1983, glyburide has been one of the most popular sulfonylureas. The American Diabetes Association (ADA) recommends the use of these agents as part of a stepwise approach to treating type 2 diabetes mellitus.
Christopher Sands, MD
Advertisement
Articles by Christopher Sands, MD
Advertisement
Latest Updated Articles
- Sulfonylurea-Induced Hypoglycemia: The Case Against Glyburide
Published: February 18th 2011 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
John Anderson, MD on How to Integrate CGM in Primary Care: "Just Do It"
2
The Menopause Society 2025 Annual Meeting: A Primary Care Preview
3
Obesity Still Plagues the US, But Rates Are Declining in Some States: The Trust for America's Health Report
4
Multidisciplinary Lung Cancer Screening Program Achieves Screening Rates Above 70%
5
